Nav: Home

Researchers use light to manipulate mosquitoes

June 16, 2017

Scientists at the University of Notre Dame have found that exposure to just 10 minutes of light at night suppresses biting and manipulates flight behavior in the Anopheles gambiae mosquito, the major vector for transmission of malaria in Africa, according to new research published in the journal Parasites and Vectors.

Critical behaviors exhibited by the species, such as feeding, egg laying and flying, are time-of-day specific, including a greater propensity for nighttime biting. A recent report from the World Health Organization stated an estimated 212 million people worldwide are infected with the disease, resulting in 429,000 deaths annually -- mostly children.

Insecticide-treated bed nets and walls have helped prevent bites and reduce malaria, but researchers say mosquitoes are adapting to preventive conditions, leaving adults and children vulnerable in the early evening and early morning hours -- when they are not under the nets or in the house.

"Anopheline mosquitoes are adapting to these current methods by developing resistance to insecticides and by shifting feeding to earlier in the evening or later into the early morning, times of the day when people are not in bed and therefore not protected by a net. So what used to be an efficient method is becoming less effective," said Giles Duffield, associate professor of biology in the Department of Biological Sciences at the University of Notre Dame and the Eck Institute for Global Health, who specializes in the molecular biology of circadian rhythms and photobiology in mammals and mosquitoes. "We need to discover new methods to address mosquito control and prevention. The systems and tools we currently have including global distribution and usage of insecticide-treated bed nets and spraying are not enough."

For the study, Duffield and his team tested the mosquitoes' preference to bite during their active host-seeking period by separating them into multiple control and test batches. Control mosquitoes were kept in the dark, while test batches were exposed to a pulse of white light for 10 minutes. Researchers then tested the propensity of the mosquitoes to bite immediately after the pulse and every two hours throughout the night, holding their arms to a mesh lining that allowed uninfected mosquitoes to feed while remaining contained. Results indicated a significant suppression. In another experiment, mosquitoes were pulsed with light every two hours, and using this multiple pulse approach the team found that biting could be suppressed during a large portion of the 12-hour night.

"Most remarkable is the prolonged effect a short light treatment has on their preference to bite, with suppression lasting as long as four hours after the pulse," Duffield said. "This may prove to be an effective tool that complements established control methods used to reduce disease transmission."

Pulses of light would probably be more effective than constant exposure, Duffield said, as the mosquitoes would be less likely to adapt to light presented in periodic doses. The research team is testing the effectiveness of different wavelengths of light, such as red light, that would be less disturbing to adults and children while they sleep, with an aim toward developing field-applicable solutions.
-end-
The work was funded by grants from the National Institute of General Medical Sciences and the University of Notre Dame's Eck Institute for Global Health.

University of Notre Dame

Related Malaria Articles:

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the Umeå University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.
Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.
New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.
Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.
Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.
Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.
Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.
Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.
The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.
Free malaria tests coupled with diagnosis-dependent vouchers for over-the-counter malaria treatment
Coupling free diagnostic tests for malaria with discounts on artemisinin combination therapy (ACT) when malaria is diagnosed can improve the rational use of ACTs and boost testing rates, according to a cluster-randomized trial published this week in PLOS Medicine by Wendy Prudhomme O'Meara of Duke University, USA, and colleagues.
More Malaria News and Malaria Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.